Page 84 - 《中国药房》2022年23期
P. 84

管已知 SIRT1 通路可通过调节过氧化物酶体增殖物激                         [11]  CHUANG Y C,CHEN S D,JOU S B,et al. Sirtuin 1 regu‐
          活受体γ共激活因子1α参与线粒体生物发生                   [23―24] ,但目       lates  mitochondrial  biogenesis  and  provides  an  endoge-
          前尚无关于SIRT1影响癫痫的报道。本研究结果表明,                               nous  neuroprotective  mechanism  against  seizure-induced
          在常规VPA血药浓度范围内治疗癫痫时,与SIRT1低表                              neuronal  cell  death  in  the  Hippocampus  following  status
          达治疗组癫痫患者比较,SIRT1 高表达治疗组患者控制                              epilepticus[J]. Int J Mol Sci,2019,20(14):E3588.
                                                              [12]  MISHRA  P,MITTAL A  K,KALONIA  H,et  al.  SIRT1
          癫痫发作效果不佳,推测SIRT1高表达很有可能与癫痫
                                                                   promotes  neuronal  fortification  in  neurodegenerative  di-
          难治有关。
                                                                   seases  through  attenuation  of  pathological  hallmarks  and
              综上所述,在 VPA 有效血药浓度范围内治疗癫痫,
                                                                   enhancement of cellular lifespan[J]. Curr Neuropharmacol,
          血清SIRT1高表达患者的癫痫可能更难控制;增加VPA
                                                                   2021,19(7):1019-1037.
          剂量后,可提高癫痫发作的有效控制率。本文为揭示                             [13]  HALL A M,BRENNAN G P,NGUYEN T M,et al. The
          SIRT1对癫痫发作和癫痫治疗的影响提供了一定的研究                               role of SIRT1 in epileptogenesis[J]. eNeuro,2017,4(1):
          基础。由于癫痫是一个极其复杂的生理病理过程,且本                                 301-316.
          文临床样本量较少,后期SIRT1低表达加量组临床样本                          [14]  陈永平,谢运兰,王衡,等 . SIRT1 在癫痫患者及大鼠脑
          量更少,组间比较存在一定的局限性,为更好地控制癫                                 组织中的表达与活性[J]. 南方医科大学学报,2013,33
          痫发作,本课题组下一步将增加临床样本量,探索SIRT1                             (4):528-532.
          在癫痫中的作用机制。                                          [15]  李烈权 . 丙戊酸钠治疗癫痫的血药浓度监测与分析[J].
          参考文献                                                     中国临床药理学杂志,2013,29(8):631-632.
          [ 1 ]  MEGIDDO I,COLSON A,CHISHOLM D,et al. Health   [16]  VIANA-MATTIOLI  S,NUNES  P,CAVALLI  R,et  al.
               and  economic  benefits  of  public  financing  of  epilepsy   Analysis of SIRT1 expression in plasma and in an in vitro
               treatment  in  India:an  agent-based  simulation  model[J].   model of preeclampsia[J]. Oxid Med Cell Longev,2020,
                                                                   2020:4561083.
               Epilepsia,2016,57(3):464-474.
          [ 2 ]  LÖSCHER  W,POTSCHKA  H,SISODIYA  S  M,et  al.   [17]  曾艳,刘立丽,闫素英.丙戊酸钠血清浓度接近或超过治
               Drug  resistance  in  epilepsy:clinical  impact,potential   疗浓度范围上限患者的肝功能、血常规结果分析[J]. 中
               mechanisms,and  new  innovative  treatment  options[J].   国药物应用与监测,2013,10(2):66-70.
                                                              [18]  中华医学会 . 临床诊疗指南:癫痫病分册(2015 年修订
               Pharmacol Rev,2020,72(3):606-638.
          [ 3 ]  MISHRA M K,KUKAL S,PAUL P R,et al. Insights into   版)[M].北京:人民卫生出版社,2015:44-46.
               structural modifications of valproic acid and their pharma‐  [19]  LI M,WANG C Y,RONG B X. Effects of valproic acid on
                                                                   skeletal metabolism in children with epilepsy:a systematic
               cological profile[J]. Molecules,2021,27(1):104.
          [ 4 ]  牛茜,崔华伟,王维平.癫痫及抗癫痫药对癫痫患者认知                         evaluation and meta-analysis based on 14 studies[J]. BMC
               功 能 的 影 响 [J]. 河 北 医 科 大 学 学 报 ,2018,39(3):         Pediatr,2020,20(1):97.
               356-359.                                       [20]  ABUALHASAN  M,ODEH  N  W,YOUNIS  G  N,et  al.
                                                                   Analytical  method  development  for  sodium  valproate
          [ 5 ]  中国抗癫痫协会.临床诊疗指南:癫痫病分册:2015修订
               版[M].北京 :人民卫生出版社,2015:113.                          through  chemical  derivatization[J].  Int  J  Anal  Chem,
          [ 6 ]  ROMOLI M,MAZZOCCHETTI P,D’ALONZO R,et al.         2020,2020:5672183.
                                                              [21]  罗媛,张慧明 . 164 例/次丙戊酸钠血药浓度监测影响因
               Valproic acid and epilepsy:from molecular mechanisms to
                                                                   素和安全用药分析[J].当代医学,2020,26(3):104-105.
               clinical  evidences[J].  Curr  Neuropharmacol,2019,17
              (10):926-946.                                   [22]  TSENG Y J,HUANG S Y,KUO C H,et al. Safety range
          [ 7 ]  VIDAURRE  J,GEDELA  S,YAROSZ  S.  Antiepileptic   of free valproic acid serum concentration in adult patients
                                                                   [J]. PLoS One,2020,15(9):e0238201.
               drugs and liver disease[J]. Pediatr Neurol,2017,77:23-36.
          [ 8 ]  CHATEAUVIEUX  S,MORCEAU  F,DICATO  M,et  al.   [23]  ZHOU Y,WANG S H,LI Y X,et al. SIRT1/PGC-1α sig‐
               Molecular  and  therapeutic  potential  and  toxicity  of  val‐  naling promotes mitochondrial functional recovery and re‐
               proic acid[J]. J Biomed Biotechnol,2010,2010:479364.  duces  apoptosis  after  intracerebral  hemorrhage  in  rats[J].
                                                                   Front Mol Neurosci,2018,10:443.
          [ 9 ]  OSÓRIO C M,LIN K,GUARNIERI R,et al. Mitochon‐
               drial respiratory chain complex enzyme activities of limbic   [24]  LIU P,ZOU D,YI L,et al. Quercetin ameliorates hypo‐
               structures  and  psychiatric  diagnosis  in  temporal  lobe       baric hypoxia-induced memory impairment through mito‐
                                                                   chondrial and neuron function adaptation via the PGC-1α
               epilepsy  patients:preliminary  results[J].  CNS  Neurosci
               Ther,2017,23(8):700-702.                            pathway[J].  Restor  Neurol  Neurosci,2015,33(2):
          [10]  HOUTKOOPER R H,PIRINEN E,AUWERX J. Sirtuins        143-157.
                                                                            (收稿日期:2022-06-07  修回日期:2022-08-23)
               as  regulators  of  metabolism  and  healthspan[J].  Nat  Rev
                                                                                                  (编辑:舒安琴)
               Mol Cell Biol,2012,13(4):225-238.


          · 2890 ·    China Pharmacy  2022 Vol. 33  No. 23                            中国药房  2022年第33卷第23期
   79   80   81   82   83   84   85   86   87   88   89